Paul Boutros, PhD, MBA
Biomarkers for Prostate Cancer
Molecular diagnostics are routine in some tumour types, but not yet in prostate cancer. However, a series of assays are seeing gradual increases in adoption rate, and several of these show the potential to improve stratification of patients with localized disease into groups with distinct risks of relapse. This session will overview these, distinguishing the relative roles of germline and somatic markers, and highlighting the future development efforts that will be needed to bring them into routine usage. We also discuss how genomic assays may be layered with pathology, radiology and other prognostic tests.
Dr. Paul Boutros began his career as a chemist at the University of Waterloo, before moving into Medical Biophysics and ultimately computational oncology at the University of Toronto. He spent a decade at the Ontario Institute for Cancer Research in Toronto, leading the Canadian Prostate Cancer Genome Network. In 2018 he relocated to the University of California, Los Angeles, where he is the Director of Cancer Data Science and a Professor in Urology and Human Genetics.
Director Cancer Data Science, Jonsson Comprehensive Cancer Centre, University of California, Los Angeles
Associate Director Cancer Informatics, Institute for Precision Health, University of California
Professor, Departments of Human Genetics and Urology, University of California, Los Angeles
Pete Bridge, PhD
Nurturing Curiosity in the Radiotherapy Workforce
Advances in automation and AI technology in radiotherapy not only bring great benefits in terms of efficiency and accuracy but also have the potential to reduce human input into the process. It is important that human clinicians retain oversight in radiotherapy and continue to drive ongoing improvements. Against this backdrop it is increasingly important that the workforce is encouraged to critique, challenge and drive innovation in the workplace. This can best be achieved by adopting a curious approach to clinical practice and life in general. This spirit of enquiry should be actively encouraged in radiotherapy education and this keynote highlights key examples of where an enquiry-based approach has led to innovation which can not only change practice but also inspire a new generation of inquisitive minds.
Pete is currently a senior lecturer in Radiotherapy at the University of Liverpool where he teaches radiotherapy planning, physics and research skills. Prior to this, he worked as a senior lecturer and undergraduate course coordinator at Queensland University of Technology in Brisbane, Australia. Pete’s research interests lie in innovative radiotherapy education and particularly the use of simulation. He conducted the first evaluation of a virtual linear accelerator educational resource prior to its commercialisation as VERT (Virtual Environment for Radiotherapy Training) and led a funded project to develop and evaluate a medical imaging 3D immersive educational environment. He has published on a wide range of educational innovations ranging from VR applications to engaging patients to provide student feedback. He co-authored the “CT Anatomy for Radiotherapy” textbook and currently delivers training on MR Anatomy for Radiotherapy. Pete’s PhD concerned the use of 3D immersive visualisation for radiotherapy structure outlining and he has just completed supervision of another project investigating use of 3D VR for IGRT image fusion. Despite this he maintains that he is not a geek. In his spare time he enjoys mountains, mud and good beer.
Sophie Foxcroft BSc., MRT(T), MHSc., CHE
Planning the Way Forward
Planning is essential to delivering health care that is person-centred, safe and effective in an efficient, equitable and timely manner. Multi-year strategic and capacity plans continue to drive improvements in the quality and performance of Ontario’s cancer system and contribute to the sustainability of the health system. Plans that are designed to anticipate and be responsive to changing clinical practice, new models of care, and emerging technologies are needed in our ever-evolving health landscape. This session will explore the development and application of various regional and provincial cancer planning models in Ontario.
Sophie Foxcroft is the Director of System and Infrastructure Planning at Cancer Care Ontario where she leads strategic system planning and capacity planning to ensure a sustainable health system. Sophie’s key responsibilities include: development of the Ontario Cancer Plan; oversight of capital investment strategies; infrastructure planning for diagnostic and treatment facilities; health human resource workforce planning for oncology specialists; and service volume planning for complex malignant hematology, cancer imaging, radiation treatment and palliative care. Prior to joining CCO, Sophie was Director of Operations for the Radiation Medicine Program at Princess Margaret Cancer Centre, UHN where she had responsibility for ensuring the delivery of safe, high quality radiation therapy to over 8,000 patients per year and implementing multi-million dollar infrastructure and capital investments to improve care for patients. She was the inaugural CCO Clinical Quality Lead, Radiation Treatment Program, and co-lead on a province-wide radiation oncology peer review audit that resulted in established provincial guidelines and identified key metrics and success indicators to evaluate peer review practice. Sophie trained as a radiation therapist at the Princess Margaret Hospital School of Radiation Therapy, holds a MHSc in Health Administration from the University of Toronto and is a Certified Health Executive with the Canadian College of Health Leaders.
Charles Washington, MBA, RT(T), ARRT, FASRT
Making the Impossible Possible: Inspiring the Development of Obtainable Performance Goals for Radiation Oncology Practice
Developing a Radiation Oncology practice is at best a challenging and difficult task and many administrators and chiefs put in an abundant amount of effort to ensure their practice thrives and delivers the level of care intended to patients. Having clear objectives and goals are critical in implementing the right strategies at the right time, making the operations smooth and manageable. This presentation will explore development of objectives and goal setting strategies in preparation for successfully delivering appropriate care as designed. An exploration of strategic and tactical tools will be discussed.
Charles serves as the Senior Director in Radiation Oncology at Memorial Sloan-Kettering Cancer Center in New York, NY serving in this role since 2012. Prior to his transition to New York, Charles served as Director of Proton Therapy, Clinical Director of Operations, Radiation Therapy Program Director, and Certified Radiation Therapist at The University of Texas M.D. Anderson Cancer Center in Houston, TX for 25 years.
Charles started his therapy career after graduation from Wayne State University’s Radiation Therapy Technology Program in Detroit, Michigan, with a baccalaureate degree in science. He received his Masters in Business Administration from the Keller Graduate School of Management of DeVry University. Charles is currently matriculating in the Doctoral Program in Organizational Change and Leadership at the University of Southern California. Charles’ dissertation is an explanatory sequential mixed methodology review of service recovery impact on patient experience and satisfaction in radiation oncology.
Charles has also served as an American Society of Radiologic Technologist appointed Trustee of the American Registry of Radiologic Technologists, having completed eight years of service on that board, and as well, an ARRT appointed Board Trustee of the American Board of Imaging Informatics, serving for over four years. Charles has edited and authored many professional articles and books, inclusive of the Principles and Practice of Radiation Therapy textbook published by Mosby, currently developing a fifth edition. Charles has instructed and lectured on the local, regional, national, and international levels.